Synthetic cannabinoids.

Area of Science:

• Forensic Toxicology
• Pharmacology
• Emergency Medicine

Background:

• Increasing use of synthetic cannabinoids, often more potent than natural cannabis.
• Challenges in detecting synthetic cannabinoids with standard drug tests.
• Rapid emergence of new synthetic cannabinoid compounds despite regulations.

Approach:

• Comparison of synthetic cannabinoids as potent, complete agonists versus natural Δ 9-tetrahydrocannabinoid as a partial agonist.
• Analysis of clinical effects necessitating emergency services and hospitalizations.
• Review of current supportive treatment strategies including benzodiazepines and antipsychotics.

Key Points:

• Synthetic cannabinoids are potent agonists of cannabinoid receptors, leading to stronger effects than natural cannabis.
• Clinical manifestations can be severe, often requiring emergency medical intervention.
• Lack of specific antidotes necessitates symptomatic treatment and supportive care.

Conclusions:

• Continued clinical follow-up studies are essential for understanding synthetic cannabinoid toxicity.
• Improved diagnostic methods and treatment protocols are needed for managing synthetic cannabinoid intoxication.
• The dynamic nature of synthetic cannabinoid production requires ongoing research and regulatory adaptation.